METHODS OF TREATING BRAIN CANCER
Disclosed herein are pharmaceutical compositions for the treatment of cancer. In particular, disclosed herein are methods and uses of the pharmaceutical compositions for treating, preventing and/or managing cancers of the brain and/or central nervous system. The pharmaceutical compositions may compr...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English French |
Published |
09.02.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Disclosed herein are pharmaceutical compositions for the treatment of cancer. In particular, disclosed herein are methods and uses of the pharmaceutical compositions for treating, preventing and/or managing cancers of the brain and/or central nervous system. The pharmaceutical compositions may comprise: (i) 5-FU, a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable analogue thereof; (ii) folinic acid, or a pharmaceutically acceptable salt thereof; and (iii) a cyclodextrin or a pharmaceutically acceptable salt thereof.
Des compositions pharmaceutiques pour le traitement du cancer sont divulguées. Des procédés et des utilisations des compositions pharmaceutiques pour le traitement, la prévention et/ou la gestion de cancers du cerveau et/ou du système nerveux central sont, en particulier, divulgués. Les compositions pharmaceutiques peuvent comprendre : (i) 5-FU, un sel pharmaceutiquement acceptable de celui-ci ou un analogue pharmaceutiquement acceptable de celui-ci ; (ii) de l'acide folinique ou un sel pharmaceutiquement acceptable de celui-ci ; et (iii) une cyclodextrine ou un sel pharmaceutiquement acceptable de celle-ci. |
---|---|
Bibliography: | Application Number: WO2021AU50848 |